Antonius ziekenhuis Sneek
- Address
- Bolswarderbaan 1, 8601 ZK Sneek, The Netherlands
Cardiovascular and Respiratory Research
At Antonius ziekenhuis Sneek, clinical trials in cardiovascular diseases and respiratory tract diseases are exploring whether adding common treatments can better protect hospitalized patients with pneumonia or influenza from serious heart complications such as myocardial infarction and acute coronary events.
- Preventing heart complications in patients with pneumonia or influenza
- Studying treatment strategies for acute coronary risk in hospitalized patients
- Evaluating how supportive therapies may improve outcomes in infection-related illness
This work focuses on improving treatment effectiveness and reducing preventable complications in acutely ill patients.
Oncology Research in Breast and Colon Cancer
The site is also involved in neoplasm research, with studies in breast cancer, triple negative breast cancer, and resected colon carcinoma. These trials are testing ways to improve survival and disease control through better use of established cancer therapies and new treatment combinations.
- Improving survival after surgery for colon cancer
- Testing treatment strategies for hormone receptor-positive metastatic breast cancer
- Evaluating added therapy for residual triple negative breast cancer
Research in this area aims to refine cancer care, strengthen long-term outcomes, and support more effective treatment planning.
Hematology and Blood Cancer Studies
Clinical research in hemic and lymphatic diseases includes work in chronic lymphocytic leukemia. These studies are examining whether treatment combinations can help patients reach deeper remission and improve overall disease response.
- Assessing remission-focused treatment approaches in chronic lymphocytic leukemia
- Exploring ways to improve measurable disease control in blood cancers
- Supporting better outcomes for patients with persistent or residual disease
The emphasis is on improving effectiveness of therapy and helping more patients achieve stronger treatment responses.
Intensive Care and Health Care Quality Research
Within Anesthesiology and Intensive Care, the research portfolio includes studies in health care quality, access, and evaluation as well as acute critical illness. The Intensive Care Platform Trial is examining interventions used in adults admitted to the intensive care unit, with the goal of improving care for critically ill patients.
- Evaluating interventions for adults admitted to intensive care
- Studying care approaches in acute critical illness
- Improving everyday intensive care practice and patient outcomes
This research supports better decision-making in critical care and helps clarify which treatments offer the greatest benefit in real-world hospital settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Antonius ziekenhuis Sneek
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | Leids Universitair Medisch Centrum (LUMC) | Phase III | Not Recruiting | Aug 2014 | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 3 | Unknown | 2024-10-14 | 2026-07-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.